FDA Inspection 1074022 — Jiangsu Lianhuan Pharmaceutical Co., Ltd
The FDA completed an inspection of Jiangsu Lianhuan Pharmaceutical Co., Ltd on Nov 7, 2018 in Yangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yangzhou (China)